Free Trial

Franklin Covey (FC) Financials

Franklin Covey logo
$22.89 -0.34 (-1.46%)
Closing price 05/23/2025 03:59 PM Eastern
Extended Trading
$22.88 -0.02 (-0.07%)
As of 05/23/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Franklin Covey

Annual Income Statements for Franklin Covey

This table shows Franklin Covey's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 8/31/2024 8/31/2023 8/31/2022
Net Income / (Loss) Attributable to Common Shareholders
24 17 17
Consolidated Net Income / (Loss)
23 18 18
Net Income / (Loss) Continuing Operations
23 18 18
Total Pre-Tax Income
33 26 22
Total Operating Income
33 26 24
Total Gross Profit
221 213 202
Total Revenue
287 281 263
Operating Revenue
287 281 263
Total Cost of Revenue
66 67 61
Operating Cost of Revenue
66 67 61
Total Operating Expenses
188 187 178
Selling, General & Admin Expense
176 178 168
Depreciation Expense
3.91 4.27 4.90
Amortization Expense
4.25 4.34 5.27
Impairment Charge
0.93 0.00 0.00
Restructuring Charge
3.01 0.57 0.00
Total Other Income / (Expense), net
0.00 -0.49 -1.61
Interest Expense
1.12 1.58 1.68
Interest & Investment Income
1.12 1.09 0.07
Income Tax Expense
9.64 8.09 3.63
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)
-0.22 0.45 1.25
Basic Earnings per Share
$1.78 $1.30 $1.30
Weighted Average Basic Shares Outstanding
13.17M 13.64M 14.15M
Diluted Earnings per Share
$1.74 $1.24 $1.27
Weighted Average Diluted Shares Outstanding
13.47M 14.30M 14.56M
Weighted Average Basic & Diluted Shares Outstanding
13.18M 13.43M 13.90M

Quarterly Income Statements for Franklin Covey

This table shows Franklin Covey's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022
Period end date 2/28/2025 11/30/2024 8/31/2024 5/31/2024 2/29/2024 11/30/2023 8/31/2023 5/31/2023 2/28/2023 11/30/2022 8/31/2022
Net Income / (Loss) Attributable to Common Shareholders
-1.12 0.98 12 5.55 0.74 4.90 6.49 4.42 1.89 4.54 4.33
Consolidated Net Income / (Loss)
-1.08 1.18 12 5.72 0.87 4.85 6.81 4.56 1.74 4.67 5.58
Net Income / (Loss) Continuing Operations
-1.08 1.18 12 5.72 0.87 4.85 6.81 4.56 1.74 4.67 5.58
Total Pre-Tax Income
-1.35 1.59 18 8.36 1.42 5.28 10 6.58 2.78 6.06 8.28
Total Operating Income
-1.46 1.48 18 8.34 1.44 5.33 11 6.57 2.83 6.39 8.66
Total Gross Profit
46 53 66 56 47 52 59 54 47 53 59
Total Revenue
60 69 84 73 61 68 78 71 62 69 79
Operating Revenue
60 69 84 73 61 68 78 71 62 69 79
Total Cost of Revenue
14 16 18 17 14 16 19 17 15 17 20
Operating Cost of Revenue
14 16 18 17 14 16 19 17 15 17 20
Total Operating Expenses
47 51 48 48 45 47 49 48 44 46 50
Selling, General & Admin Expense
45 47 45 45 41 44 46 46 42 44 48
Depreciation Expense
1.02 0.95 0.91 0.99 0.91 1.09 1.14 0.93 0.95 1.25 1.22
Amortization Expense
1.10 1.10 1.04 1.06 1.07 1.07 1.07 1.09 1.09 1.09 1.16
Impairment Charge
0.00 - - 0.00 0.93 - - 0.00 0.00 - -
Restructuring Charge
0.00 1.98 - 0.70 1.73 0.58 - 0.00 0.00 - -
Total Other Income / (Expense), net
0.11 0.11 0.06 0.02 -0.03 -0.05 -0.12 0.01 -0.05 -0.33 -0.38
Interest Expense
0.16 0.18 0.20 0.25 0.33 0.34 0.41 0.35 0.41 0.41 0.40
Interest & Investment Income
0.26 0.29 0.27 0.27 0.30 0.29 0.29 0.36 0.36 0.08 0.02
Income Tax Expense
-0.27 0.41 6.04 2.64 0.54 0.43 3.63 2.02 1.04 1.40 2.70
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)
0.04 0.20 -0.48 0.18 0.14 -0.05 0.32 0.14 -0.15 0.13 -
Basic Earnings per Share
($0.08) $0.09 $0.91 $0.43 $0.07 $0.37 $0.50 $0.33 $0.13 $0.34 $0.39
Weighted Average Basic Shares Outstanding
13.10M 13.09M 13.17M 13.16M 13.26M 13.24M 13.64M 13.62M 13.90M 13.88M 14.15M
Diluted Earnings per Share
($0.08) $0.09 $0.89 $0.43 $0.06 $0.36 $0.48 $0.32 $0.12 $0.32 $0.36
Weighted Average Diluted Shares Outstanding
13.10M 13.27M 13.47M 13.38M 13.48M 13.64M 14.30M 14.27M 14.53M 14.51M 14.56M
Weighted Average Basic & Diluted Shares Outstanding
12.99M 13.20M 13.18M 13.09M 13.27M 13.29M 13.43M 13.20M 13.85M 13.91M 13.90M

Annual Cash Flow Statements for Franklin Covey

This table details how cash moves in and out of Franklin Covey's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 8/31/2024 8/31/2023 8/31/2022
Net Change in Cash & Equivalents
10 -22 13
Net Cash From Operating Activities
60 36 52
Net Cash From Continuing Operating Activities
60 36 52
Net Income / (Loss) Continuing Operations
23 18 18
Consolidated Net Income / (Loss)
23 18 18
Depreciation Expense
8.15 8.61 10
Amortization Expense
3.93 3.92 4.27
Non-Cash Adjustments To Reconcile Net Income
11 13 8.29
Changes in Operating Assets and Liabilities, net
14 -7.09 11
Net Cash From Investing Activities
-11 -14 -5.33
Net Cash From Continuing Investing Activities
-11 -14 -5.33
Purchase of Property, Plant & Equipment
-3.69 -4.52 -3.18
Acquisitions
-0.75 0.00 0.00
Other Investing Activities, net
-6.87 -9.04 -2.15
Net Cash From Financing Activities
-39 -44 -33
Net Cash From Continuing Financing Activities
-39 -44 -33
Repayment of Debt
-9.37 -17 -8.72
Repurchase of Common Equity
-31 -36 -24
Issuance of Debt
0.00 7.50 0.00
Issuance of Common Equity
1.47 1.54 1.34
Other Financing Activities, net
0.00 -0.74 -1.43
Effect of Exchange Rate Changes
0.14 -0.30 -
Cash Interest Paid
1.11 1.50 1.66
Cash Income Taxes Paid
4.21 3.31 3.21

Quarterly Cash Flow Statements for Franklin Covey

This table details how cash moves in and out of Franklin Covey's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022
Period end date 2/28/2025 11/30/2024 8/31/2024 5/31/2024 2/29/2024 11/30/2023 8/31/2023 5/31/2023 2/28/2023 11/30/2022 8/31/2022
Net Change in Cash & Equivalents
-13 4.63 12 -4.33 6.95 -4.27 -1.10 -16 -3.03 -2.37 8.45
Net Cash From Operating Activities
-1.37 14 22 8.17 13 17 9.79 15 8.19 3.02 13
Net Cash From Continuing Operating Activities
-1.37 14 22 8.17 13 17 9.79 15 8.19 3.02 13
Net Income / (Loss) Continuing Operations
-1.08 1.18 12 5.72 0.87 4.85 6.81 4.56 1.74 4.67 5.58
Consolidated Net Income / (Loss)
-1.08 1.18 12 5.72 0.87 4.85 6.81 4.56 1.74 4.67 5.58
Depreciation Expense
2.12 2.05 1.96 2.05 1.98 2.16 2.21 2.02 2.04 2.34 2.38
Amortization Expense
1.26 1.20 1.00 1.03 1.01 0.89 0.90 0.96 1.01 1.05 1.20
Non-Cash Adjustments To Reconcile Net Income
1.35 2.17 3.05 2.83 2.30 2.90 3.16 3.31 3.32 2.74 2.30
Changes in Operating Assets and Liabilities, net
-5.02 7.55 3.92 -3.46 6.61 6.64 -3.30 3.89 0.08 -7.77 1.27
Net Cash From Investing Activities
-2.22 -2.75 -3.50 -2.33 -1.75 -3.74 -3.16 -2.47 -5.71 -2.21 -1.87
Net Cash From Continuing Investing Activities
-2.22 -2.75 -3.50 -2.33 -1.75 -3.74 -3.16 -2.47 -5.71 -2.21 -1.87
Purchase of Property, Plant & Equipment
-1.27 -1.00 -1.08 -0.90 -0.64 -1.07 -0.97 -0.90 -1.40 -1.24 -1.10
Other Investing Activities, net
-0.95 -1.43 -1.67 -1.43 -1.10 -2.67 -2.19 -1.56 -4.30 -0.97 -0.78
Net Cash From Financing Activities
-9.31 -6.58 -6.69 -10 -3.90 -18 -7.59 -28 -5.80 -2.92 -2.01
Net Cash From Continuing Financing Activities
-9.31 -6.58 -6.69 -10 -3.90 -18 -7.59 -28 -5.80 -2.92 -2.01
Repayment of Debt
-0.96 -0.95 -2.17 -2.98 -2.12 -2.11 -2.08 -11 -2.04 -2.02 -2.00
Repurchase of Common Equity
-8.70 -5.95 -4.91 -7.43 -2.11 -16 -5.88 -25 -3.83 -0.84 -
Issuance of Common Equity
0.36 0.32 0.39 0.39 0.33 0.36 0.38 0.42 0.37 0.37 0.33
Effect of Exchange Rate Changes
0.00 -0.18 0.40 -0.16 -0.18 0.09 -0.14 - - - -
Cash Interest Paid
0.12 0.14 0.18 0.32 0.28 0.34 0.34 0.42 0.37 0.37 0.36
Cash Income Taxes Paid
5.28 0.75 1.24 1.32 0.82 0.82 0.86 0.85 0.77 0.84 1.47

Annual Balance Sheets for Franklin Covey

This table presents Franklin Covey's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 8/31/2024 8/31/2023 8/31/2022
Total Assets
262 246 259
Total Current Assets
160 145 156
Cash & Equivalents
49 38 61
Accounts Receivable
86 82 73
Inventories, net
4.00 4.21 3.53
Prepaid Expenses
22 4.40 4.71
Plant, Property, & Equipment, net
8.74 10 9.80
Total Noncurrent Assets
93 91 93
Goodwill
31 31 31
Intangible Assets
38 41 45
Noncurrent Deferred & Refundable Income Taxes
0.87 1.66 4.69
Other Noncurrent Operating Assets
23 17 13
Total Liabilities & Shareholders' Equity
262 246 259
Total Liabilities
178 167 176
Total Current Liabilities
162 152 154
Short-Term Debt
0.84 5.84 5.84
Accounts Payable
7.86 6.50 11
Accrued Expenses
32 28 34
Customer Deposits
17 12 -
Current Deferred Revenue
101 95 86
Other Current Liabilities
3.11 3.54 17
Total Noncurrent Liabilities
16 16 23
Long-Term Debt
0.78 1.54 7.27
Noncurrent Deferred & Payable Income Tax Liabilities
3.13 2.04 0.20
Other Noncurrent Operating Liabilities
12 12 15
Total Equity & Noncontrolling Interests
83 79 83
Total Preferred & Common Equity
83 79 83
Total Common Equity
83 79 83
Common Stock
233 234 222
Retained Earnings
123 100 82
Treasury Stock
-272 -254 -220
Accumulated Other Comprehensive Income / (Loss)
-0.77 -0.99 -0.54

Quarterly Balance Sheets for Franklin Covey

This table presents Franklin Covey's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2025 Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 2/28/2025 11/30/2024 5/31/2024 2/29/2024 11/30/2023 5/31/2023 2/28/2023 11/30/2022 5/31/2022
Total Assets
221 240 221 222 219 218 234 237 228
Total Current Assets
121 139 120 122 117 117 131 136 122
Cash & Equivalents
40 53 37 41 34 39 55 58 52
Accounts Receivable
53 61 60 57 60 55 54 57 50
Inventories, net
4.09 3.83 4.64 4.20 4.12 4.57 3.47 3.48 3.36
Prepaid Expenses
23 20 18 20 19 17 19 17 16
Plant, Property, & Equipment, net
9.55 8.73 8.63 8.71 9.52 9.70 9.85 9.47 9.59
Total Noncurrent Assets
91 92 92 91 92 91 93 92 97
Goodwill
31 31 31 31 31 31 31 31 31
Intangible Assets
36 37 39 38 39 42 43 44 46
Noncurrent Deferred & Refundable Income Taxes
0.82 0.83 1.64 1.66 1.68 2.27 3.56 4.28 6.27
Other Noncurrent Operating Assets
23 23 21 20 20 16 16 12 13
Total Liabilities & Shareholders' Equity
221 240 221 222 219 218 234 237 228
Total Liabilities
149 159 149 151 148 143 143 148 153
Total Current Liabilities
134 144 137 138 135 128 125 128 129
Short-Term Debt
0.84 0.84 2.09 3.34 4.59 5.84 5.84 5.84 5.84
Accounts Payable
6.80 5.96 6.19 7.73 5.67 7.10 8.49 6.88 8.07
Accrued Expenses
17 24 22 19 21 24 19 23 29
Customer Deposits
20 22 22 - - - - - -
Current Deferred Revenue
88 89 80 82 83 70 74 74 67
Other Current Liabilities
1.20 2.17 3.81 26 20 21 18 17 20
Total Noncurrent Liabilities
15 16 12 13 14 15 18 20 25
Long-Term Debt
0.80 0.79 0.76 1.58 1.56 2.76 4.82 6.05 8.49
Noncurrent Deferred & Payable Income Tax Liabilities
2.98 2.91 1.85 1.06 1.01 0.20 0.20 0.20 0.38
Other Noncurrent Operating Liabilities
11 12 9.61 10 11 12 13 14 16
Total Equity & Noncontrolling Interests
73 81 72 71 71 75 91 90 75
Total Preferred & Common Equity
73 81 72 71 71 75 91 90 75
Total Common Equity
73 81 72 71 71 75 91 90 75
Common Stock
229 229 230 227 226 230 227 224 219
Retained Earnings
123 124 111 106 105 93 88 87 76
Treasury Stock
-279 -271 -268 -261 -259 -248 -224 -220 -221
Accumulated Other Comprehensive Income / (Loss)
-1.01 -0.97 -1.25 -1.08 -0.94 -0.67 -0.53 -0.67 -0.20

Annual Metrics And Ratios for Franklin Covey

This table displays calculated financial ratios and metrics derived from Franklin Covey's official financial filings.

Metric 2024 2023 2022
Period end date 8/31/2024 8/31/2023 8/31/2022
Growth Metrics
- - -
Revenue Growth
2.39% 6.73% 17.25%
EBITDA Growth
16.03% 2.05% 60.50%
EBIT Growth
25.34% 11.35% 192.24%
NOPAT Growth
29.14% -8.37% 8.85%
Net Income Growth
31.61% -3.52% 35.29%
EPS Growth
40.32% -2.36% 32.29%
Operating Cash Flow Growth
68.61% -31.61% 13.16%
Free Cash Flow Firm Growth
513.28% -83.93% 85.32%
Invested Capital Growth
-24.51% 35.01% -30.93%
Revenue Q/Q Growth
2.20% -0.30% 3.90%
EBITDA Q/Q Growth
18.98% 3.85% 11.83%
EBIT Q/Q Growth
28.65% 7.79% 22.52%
NOPAT Q/Q Growth
27.25% 6.13% 23.21%
Net Income Q/Q Growth
28.17% 7.46% 25.72%
EPS Q/Q Growth
30.83% 10.71% 23.30%
Operating Cash Flow Q/Q Growth
25.08% -7.57% -4.75%
Free Cash Flow Firm Q/Q Growth
47.95% -45.46% -31.71%
Invested Capital Q/Q Growth
-6.12% 9.18% -4.85%
Profitability Metrics
- - -
Gross Margin
76.97% 76.10% 76.82%
EBITDA Margin
15.71% 13.86% 14.50%
Operating Margin
11.50% 9.40% 9.01%
EBIT Margin
11.50% 9.40% 9.01%
Profit (Net Income) Margin
8.15% 6.34% 7.01%
Tax Burden Percent
70.82% 68.73% 83.53%
Interest Burden Percent
100.01% 98.13% 93.20%
Effective Tax Rate
29.18% 31.27% 16.47%
Return on Invested Capital (ROIC)
55.79% 43.56% 45.64%
ROIC Less NNEP Spread (ROIC-NNEP)
55.79% 44.42% 49.18%
Return on Net Nonoperating Assets (RNNOA)
-26.87% -21.53% -22.98%
Return on Equity (ROE)
28.93% 22.02% 22.66%
Cash Return on Invested Capital (CROIC)
83.72% 13.76% 82.24%
Operating Return on Assets (OROA)
13.02% 10.44% 9.31%
Return on Assets (ROA)
9.22% 7.04% 7.24%
Return on Common Equity (ROCE)
28.93% 22.02% 22.66%
Return on Equity Simple (ROE_SIMPLE)
28.15% 22.61% 22.25%
Net Operating Profit after Tax (NOPAT)
23 18 20
NOPAT Margin
8.15% 6.46% 7.52%
Net Nonoperating Expense Percent (NNEP)
0.01% -0.86% -3.54%
Cost of Revenue to Revenue
23.03% 23.90% 23.18%
SG&A Expenses to Revenue
61.25% 63.44% 63.94%
R&D to Revenue
0.00% 0.00% 0.00%
Operating Expenses to Revenue
65.46% 66.71% 67.81%
Earnings before Interest and Taxes (EBIT)
33 26 24
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
45 39 38
Valuation Ratios
- - -
Price to Book Value (P/BV)
6.34 7.16 7.96
Price to Tangible Book Value (P/TBV)
37.26 81.39 97.51
Price to Revenue (P/Rev)
1.84 2.01 2.51
Price to Earnings (P/E)
22.32 32.50 38.37
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
4.48% 3.08% 2.61%
Enterprise Value to Invested Capital (EV/IC)
13.31 11.14 17.28
Enterprise Value to Revenue (EV/Rev)
1.67 1.90 2.33
Enterprise Value to EBITDA (EV/EBITDA)
10.64 13.69 16.05
Enterprise Value to EBIT (EV/EBIT)
14.53 20.20 25.84
Enterprise Value to NOPAT (EV/NOPAT)
20.52 29.39 30.94
Enterprise Value to Operating Cash Flow (EV/OCF)
7.97 14.90 11.71
Enterprise Value to Free Cash Flow (EV/FCFF)
13.67 93.02 17.17
Leverage & Solvency
- - -
Debt to Equity
0.02 0.09 0.16
Long-Term Debt to Equity
0.01 0.02 0.09
Financial Leverage
-0.48 -0.48 -0.47
Leverage Ratio
3.14 3.13 3.13
Compound Leverage Factor
3.14 3.07 2.92
Debt to Total Capital
1.90% 8.57% 13.66%
Short-Term Debt to Total Capital
0.99% 6.78% 6.08%
Long-Term Debt to Total Capital
0.91% 1.78% 7.58%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00%
Common Equity to Total Capital
98.10% 91.43% 86.34%
Debt to EBITDA
0.04 0.19 0.34
Net Debt to EBITDA
-1.04 -0.79 -1.24
Long-Term Debt to EBITDA
0.02 0.04 0.19
Debt to NOPAT
0.07 0.41 0.66
Net Debt to NOPAT
-2.01 -1.70 -2.40
Long-Term Debt to NOPAT
0.03 0.08 0.37
Altman Z-Score
3.94 4.05 4.01
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00%
Liquidity Ratios
- - -
Current Ratio
0.99 0.96 1.01
Quick Ratio
0.83 0.79 0.87
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
35 5.73 36
Operating Cash Flow to CapEx
1,631.21% 791.54% 1,644.76%
Free Cash Flow to Firm to Interest Expense
31.38 3.62 21.27
Operating Cash Flow to Interest Expense
53.85 22.58 31.20
Operating Cash Flow Less CapEx to Interest Expense
50.55 19.72 29.30
Efficiency Ratios
- - -
Asset Turnover
1.13 1.11 1.03
Accounts Receivable Turnover
3.42 3.63 3.67
Inventory Turnover
16.11 17.32 20.23
Fixed Asset Turnover
30.60 28.28 24.65
Accounts Payable Turnover
9.21 7.72 6.84
Days Sales Outstanding (DSO)
106.70 100.51 99.46
Days Inventory Outstanding (DIO)
22.66 21.07 18.04
Days Payable Outstanding (DPO)
39.62 47.28 53.35
Cash Conversion Cycle (CCC)
89.74 74.31 64.15
Capital & Investment Metrics
- - -
Invested Capital
36 48 35
Invested Capital Turnover
6.85 6.74 6.07
Increase / (Decrease) in Invested Capital
-12 12 -16
Enterprise Value (EV)
480 533 612
Market Capitalization
527 563 659
Book Value per Share
$6.35 $5.96 $5.98
Tangible Book Value per Share
$1.08 $0.52 $0.49
Total Capital
85 86 96
Total Debt
1.61 7.37 13
Total Long-Term Debt
0.78 1.54 7.27
Net Debt
-47 -31 -47
Capital Expenditures (CapEx)
3.69 4.52 3.18
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-50 -39 -53
Debt-free Net Working Capital (DFNWC)
-1.37 -0.80 7.92
Net Working Capital (NWC)
-2.20 -6.63 2.09
Net Nonoperating Expense (NNE)
-0.00 0.34 1.34
Net Nonoperating Obligations (NNO)
-47 -31 -47
Total Depreciation and Amortization (D&A)
12 13 14
Debt-free, Cash-free Net Working Capital to Revenue
-17.42% -13.91% -20.01%
Debt-free Net Working Capital to Revenue
-0.48% -0.28% 3.01%
Net Working Capital to Revenue
-0.77% -2.36% 0.79%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
$1.78 $1.30 $1.30
Adjusted Weighted Average Basic Shares Outstanding
13.17M 13.64M 14.15M
Adjusted Diluted Earnings per Share
$1.74 $1.24 $1.27
Adjusted Weighted Average Diluted Shares Outstanding
13.47M 14.30M 14.56M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
13.18M 13.43M 13.90M
Normalized Net Operating Profit after Tax (NOPAT)
26 19 20
Normalized NOPAT Margin
9.12% 6.60% 7.52%
Pre Tax Income Margin
11.50% 9.22% 8.39%
Debt Service Ratios
- - -
EBIT to Interest Expense
29.53 16.65 14.13
NOPAT to Interest Expense
20.91 11.45 11.81
EBIT Less CapEx to Interest Expense
26.23 13.80 12.24
NOPAT Less CapEx to Interest Expense
17.61 8.59 9.91
Payout Ratios
- - -
Dividend Payout Ratio
0.00% 0.00% 0.00%
Augmented Payout Ratio
131.39% 199.96% 129.41%

Quarterly Metrics And Ratios for Franklin Covey

This table displays calculated financial ratios and metrics derived from Franklin Covey's official financial filings.

Metric Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022
Period end date 2/28/2025 11/30/2024 8/31/2024 5/31/2024 2/29/2024 11/30/2023 8/31/2023 5/31/2023 2/28/2023 11/30/2022 8/31/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-2.81% 1.00% 7.91% 2.70% -0.68% -1.40% -1.08% 7.96% 9.11% 13.24% 14.30%
EBITDA Growth
-56.69% -43.71% 52.61% 19.64% -24.54% -14.27% 11.79% 0.87% -17.52% 5.47% 49.10%
EBIT Growth
-200.90% -72.32% 69.63% 26.95% -49.01% -16.63% 22.00% 10.47% -19.59% 15.28% 100.90%
NOPAT Growth
-214.35% -77.60% 72.85% 25.22% -49.63% -0.42% 18.09% -40.47% -16.84% 19.04% 189.37%
Net Income Growth
-223.11% -75.65% 75.51% 25.38% -49.74% 3.94% 22.12% -36.29% -7.40% 22.43% 208.69%
EPS Growth
-233.33% -75.00% 85.42% 34.38% -50.00% 12.50% 33.33% -37.25% -7.69% 18.52% 200.00%
Operating Cash Flow Growth
-110.72% -18.88% 123.39% -44.55% 55.95% 477.99% -23.01% -9.57% -37.35% -70.32% -17.01%
Free Cash Flow Firm Growth
-99.66% 166.12% 529.48% 647.90% 451.47% -44.12% -125.36% -104.61% -130.07% -33.70% 604.99%
Invested Capital Growth
-3.05% -32.11% -24.51% -12.20% -25.72% -1.53% 35.01% 17.67% 13.16% -10.41% -30.93%
Revenue Q/Q Growth
-13.71% -17.88% 14.65% 19.62% -10.33% -12.26% 9.12% 15.68% -10.97% -11.98% 19.09%
EBITDA Q/Q Growth
-59.24% -77.40% 82.72% 157.36% -47.02% -38.74% 43.24% 62.32% -39.81% -20.12% 29.24%
EBIT Q/Q Growth
-198.64% -91.77% 114.89% 478.57% -72.94% -49.58% 60.82% 132.39% -55.76% -26.21% 45.62%
NOPAT Q/Q Growth
-192.79% -90.79% 108.78% 540.71% -81.82% -28.92% 51.24% 157.72% -64.06% -15.70% -23.76%
Net Income Q/Q Growth
-191.11% -90.12% 108.98% 554.58% -81.98% -28.79% 49.29% 162.39% -62.74% -16.33% -22.12%
EPS Q/Q Growth
-188.89% -89.89% 106.98% 616.67% -83.33% -25.00% 50.00% 166.67% -62.50% -11.11% -29.41%
Operating Cash Flow Q/Q Growth
-109.68% -35.33% 167.61% -36.02% -26.75% 78.10% -33.57% 79.94% 171.49% -76.28% -21.97%
Free Cash Flow Firm Q/Q Growth
-99.70% -37.34% 113.84% -14.71% 132.87% 201.12% -172.80% 45.29% -137.02% -54.11% -50.45%
Invested Capital Q/Q Growth
16.55% -19.69% -6.12% 10.33% -18.39% -10.69% 9.18% -6.65% 8.19% 22.45% -4.85%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
76.74% 76.30% 78.14% 76.60% 76.38% 76.43% 76.08% 75.91% 76.45% 76.03% 74.95%
EBITDA Margin
3.23% 6.83% 24.82% 15.57% 7.24% 12.25% 17.55% 13.37% 9.53% 14.09% 15.53%
Operating Margin
-2.44% 2.14% 21.31% 11.37% 2.35% 7.79% 13.56% 9.20% 4.58% 9.21% 10.99%
EBIT Margin
-2.44% 2.14% 21.31% 11.37% 2.35% 7.79% 13.56% 9.20% 4.58% 9.21% 10.99%
Profit (Net Income) Margin
-1.81% 1.71% 14.21% 7.80% 1.42% 7.09% 8.74% 6.39% 2.82% 6.73% 7.08%
Tax Burden Percent
79.82% 74.42% 66.46% 68.40% 61.77% 91.94% 65.22% 69.35% 62.53% 76.98% 67.38%
Interest Burden Percent
92.65% 107.59% 100.35% 100.25% 98.13% 99.01% 98.83% 100.12% 98.34% 94.85% 95.57%
Effective Tax Rate
0.00% 25.58% 33.54% 31.60% 38.23% 8.06% 34.78% 30.65% 37.47% 23.02% 32.62%
Return on Invested Capital (ROIC)
-14.25% 12.77% 97.00% 53.18% 9.92% 46.56% 59.63% 44.33% 17.90% 41.90% 44.93%
ROIC Less NNEP Spread (ROIC-NNEP)
-14.10% 12.56% 96.89% 53.13% 9.96% 46.69% 59.84% 44.32% 17.97% 42.54% 45.61%
Return on Net Nonoperating Assets (RNNOA)
7.35% -6.60% -46.66% -23.35% -4.94% -21.60% -29.01% -20.30% -9.02% -19.81% -21.31%
Return on Equity (ROE)
-6.90% 6.16% 50.34% 29.83% 4.98% 24.95% 30.62% 24.03% 8.88% 22.10% 23.62%
Cash Return on Invested Capital (CROIC)
54.35% 93.01% 83.72% 57.73% 71.71% 43.67% 13.76% 25.93% 33.18% 55.78% 82.24%
Operating Return on Assets (OROA)
-3.15% 2.68% 24.13% 14.57% 2.88% 9.55% 15.06% 11.60% 5.41% 10.67% 11.36%
Return on Assets (ROA)
-2.33% 2.15% 16.09% 9.99% 1.74% 8.69% 9.71% 8.06% 3.33% 7.79% 7.31%
Return on Common Equity (ROCE)
-6.90% 6.16% 50.34% 29.83% 4.98% 24.95% 30.62% 24.03% 8.88% 22.10% 23.62%
Return on Equity Simple (ROE_SIMPLE)
24.52% 24.47% 0.00% 25.30% 24.14% 25.48% 0.00% 22.21% 20.96% 21.52% 0.00%
Net Operating Profit after Tax (NOPAT)
-1.02 1.10 12 5.71 0.89 4.90 6.89 4.56 1.77 4.92 5.84
NOPAT Margin
-1.71% 1.59% 14.16% 7.78% 1.45% 7.16% 8.84% 6.38% 2.86% 7.09% 7.41%
Net Nonoperating Expense Percent (NNEP)
-0.15% 0.21% 0.11% 0.04% -0.04% -0.13% -0.21% 0.02% -0.07% -0.63% -0.68%
Return On Investment Capital (ROIC_SIMPLE)
-1.37% 1.33% - - - 6.39% - - - - -
Cost of Revenue to Revenue
23.26% 23.70% 21.86% 23.40% 23.62% 23.57% 23.92% 24.09% 23.55% 23.97% 25.05%
SG&A Expenses to Revenue
75.63% 68.33% 53.82% 61.48% 66.47% 64.63% 58.96% 63.89% 68.56% 63.45% 60.94%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
79.18% 74.16% 56.83% 65.23% 74.03% 68.64% 62.52% 66.71% 71.87% 66.82% 63.96%
Earnings before Interest and Taxes (EBIT)
-1.46 1.48 18 8.34 1.44 5.33 11 6.57 2.83 6.39 8.66
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1.92 4.72 21 11 4.44 8.38 14 9.55 5.88 9.78 12
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
5.82 5.95 6.34 6.80 7.16 7.41 7.16 6.86 7.13 8.06 7.96
Price to Tangible Book Value (P/TBV)
80.55 39.11 37.26 229.90 410.41 0.00 81.39 299.97 37.26 49.27 97.51
Price to Revenue (P/Rev)
1.47 1.67 1.84 1.75 1.82 1.87 2.01 1.82 2.36 2.66 2.51
Price to Earnings (P/E)
23.65 24.35 22.32 27.77 30.65 29.51 32.50 33.71 36.39 40.33 38.37
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
4.23% 4.11% 4.48% 3.60% 3.26% 3.39% 3.08% 2.97% 2.75% 2.48% 2.61%
Enterprise Value to Invested Capital (EV/IC)
11.35 14.77 13.31 11.89 13.53 11.58 11.14 10.98 12.95 15.59 17.28
Enterprise Value to Revenue (EV/Rev)
1.34 1.49 1.67 1.63 1.69 1.77 1.90 1.71 2.20 2.49 2.33
Enterprise Value to EBITDA (EV/EBITDA)
9.84 10.32 10.64 12.05 13.07 13.19 13.69 12.84 16.25 17.50 16.05
Enterprise Value to EBIT (EV/EBIT)
14.58 14.66 14.53 17.80 19.71 19.55 20.20 19.66 25.48 27.56 25.84
Enterprise Value to NOPAT (EV/NOPAT)
21.80 21.81 20.52 24.86 27.33 27.29 29.39 28.16 30.20 32.89 30.94
Enterprise Value to Operating Cash Flow (EV/OCF)
8.95 7.51 7.97 9.49 8.61 9.86 14.90 12.43 15.10 14.98 11.71
Enterprise Value to Free Cash Flow (EV/FCFF)
20.56 12.84 13.67 19.26 16.08 26.33 93.02 45.79 41.43 26.41 17.17
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.02 0.02 0.02 0.04 0.07 0.09 0.09 0.12 0.12 0.13 0.16
Long-Term Debt to Equity
0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.04 0.05 0.07 0.09
Financial Leverage
-0.52 -0.53 -0.48 -0.44 -0.50 -0.46 -0.48 -0.46 -0.50 -0.47 -0.47
Leverage Ratio
3.09 3.04 3.14 2.99 2.81 2.85 3.13 2.99 2.63 2.73 3.13
Compound Leverage Factor
2.86 3.27 3.15 3.00 2.76 2.82 3.09 2.99 2.59 2.59 2.99
Debt to Total Capital
2.21% 1.97% 1.90% 3.79% 6.49% 8.01% 8.57% 10.35% 10.45% 11.70% 13.66%
Short-Term Debt to Total Capital
1.13% 1.01% 0.99% 2.78% 4.40% 5.98% 6.78% 7.02% 5.72% 5.75% 6.08%
Long-Term Debt to Total Capital
1.08% 0.96% 0.91% 1.01% 2.08% 2.03% 1.78% 3.33% 4.73% 5.96% 7.58%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
97.79% 98.03% 98.10% 96.21% 93.51% 91.99% 91.43% 89.65% 89.55% 88.30% 86.34%
Debt to EBITDA
0.04 0.04 0.04 0.08 0.14 0.16 0.19 0.23 0.29 0.31 0.34
Net Debt to EBITDA
-1.00 -1.25 -1.04 -0.89 -1.00 -0.74 -0.79 -0.82 -1.19 -1.20 -1.24
Long-Term Debt to EBITDA
0.02 0.02 0.02 0.02 0.04 0.04 0.04 0.07 0.13 0.16 0.19
Debt to NOPAT
0.09 0.08 0.07 0.15 0.28 0.34 0.41 0.50 0.53 0.58 0.66
Net Debt to NOPAT
-2.20 -2.63 -2.01 -1.83 -2.09 -1.54 -1.70 -1.80 -2.21 -2.25 -2.40
Long-Term Debt to NOPAT
0.05 0.04 0.03 0.04 0.09 0.09 0.08 0.16 0.24 0.29 0.37
Altman Z-Score
3.68 3.73 3.75 3.99 3.87 4.04 3.84 4.07 4.52 4.72 3.82
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.90 0.97 0.99 0.88 0.88 0.87 0.96 0.91 1.05 1.07 1.01
Quick Ratio
0.70 0.80 0.83 0.71 0.71 0.70 0.79 0.74 0.87 0.90 0.87
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.04 15 24 11 13 5.56 -5.50 -2.02 -3.69 9.96 22
Operating Cash Flow to CapEx
-107.54% 1,417.33% 2,032.71% 906.10% 1,983.54% 1,626.68% 1,009.38% 1,635.85% 583.40% 243.31% 1,159.34%
Free Cash Flow to Firm to Interest Expense
0.29 83.17 116.38 44.73 39.49 16.31 -13.42 -5.70 -9.01 24.28 54.10
Operating Cash Flow to Interest Expense
-8.78 79.47 107.74 33.09 38.95 51.14 23.88 41.64 20.03 7.36 31.72
Operating Cash Flow Less CapEx to Interest Expense
-16.94 73.86 102.44 29.44 36.98 47.99 21.51 39.09 16.59 4.33 28.98
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.29 1.26 1.13 1.28 1.22 1.23 1.11 1.26 1.18 1.16 1.03
Accounts Receivable Turnover
5.18 4.75 3.42 4.85 5.03 4.77 3.63 5.31 5.44 4.97 3.67
Inventory Turnover
15.87 16.72 16.11 14.41 17.34 17.52 17.32 17.18 22.21 21.10 20.23
Fixed Asset Turnover
31.34 31.55 30.60 30.67 30.08 29.45 28.28 29.17 27.77 27.03 24.65
Accounts Payable Turnover
9.06 11.42 9.21 10.00 8.19 10.61 7.72 8.98 8.72 10.34 6.84
Days Sales Outstanding (DSO)
70.42 76.87 106.70 75.26 72.50 76.52 100.51 68.69 67.06 73.45 99.46
Days Inventory Outstanding (DIO)
22.99 21.83 22.66 25.32 21.04 20.83 21.07 21.24 16.44 17.30 18.04
Days Payable Outstanding (DPO)
40.30 31.95 39.62 36.51 44.54 34.41 47.28 40.64 41.87 35.31 53.35
Cash Conversion Cycle (CCC)
53.12 66.75 89.74 64.07 49.00 62.94 74.31 49.29 41.62 55.43 64.15
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
34 29 36 38 35 43 48 44 47 43 35
Invested Capital Turnover
8.34 8.04 6.85 6.84 6.83 6.50 6.74 6.95 6.25 5.91 6.07
Increase / (Decrease) in Invested Capital
-1.06 -14 -12 -5.34 -12 -0.66 12 6.57 5.45 -5.04 -16
Enterprise Value (EV)
383 428 480 457 471 494 533 481 607 676 612
Market Capitalization
422 480 527 491 507 522 563 511 652 722 659
Book Value per Share
$5.50 $6.12 $6.35 $5.44 $5.33 $5.25 $5.96 $5.38 $6.57 $6.45 $5.98
Tangible Book Value per Share
$0.40 $0.93 $1.08 $0.16 $0.09 ($0.01) $0.52 $0.12 $1.26 $1.05 $0.49
Total Capital
74 82 85 75 76 77 86 83 102 101 96
Total Debt
1.64 1.62 1.61 2.85 4.91 6.14 7.37 8.60 11 12 13
Total Long-Term Debt
0.80 0.79 0.78 0.76 1.58 1.56 1.54 2.76 4.82 6.05 7.27
Net Debt
-39 -52 -47 -34 -36 -28 -31 -31 -44 -46 -47
Capital Expenditures (CapEx)
1.27 1.00 1.08 0.90 0.64 1.07 0.97 0.90 1.40 1.24 1.10
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-53 -57 -50 -51 -54 -47 -39 -45 -43 -44 -53
Debt-free Net Working Capital (DFNWC)
-12 -3.92 -1.37 -14 -13 -13 -0.80 -5.84 12 15 7.92
Net Working Capital (NWC)
-13 -4.75 -2.20 -17 -16 -17 -6.63 -12 5.80 8.67 2.09
Net Nonoperating Expense (NNE)
0.06 -0.08 -0.04 -0.01 0.02 0.05 0.08 -0.01 0.03 0.25 0.26
Net Nonoperating Obligations (NNO)
-39 -52 -47 -34 -36 -28 -31 -31 -44 -46 -47
Total Depreciation and Amortization (D&A)
3.38 3.24 2.95 3.08 3.00 3.05 3.11 2.98 3.06 3.38 3.58
Debt-free, Cash-free Net Working Capital to Revenue
-18.38% -19.87% -17.42% -18.16% -19.20% -16.75% -13.91% -16.05% -15.75% -16.11% -20.01%
Debt-free Net Working Capital to Revenue
-4.26% -1.36% -0.48% -5.15% -4.55% -4.60% -0.28% -2.08% 4.21% 5.35% 3.01%
Net Working Capital to Revenue
-4.55% -1.65% -0.77% -5.89% -5.74% -6.24% -2.36% -4.15% 2.10% 3.20% 0.79%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.08) $0.09 $0.91 $0.43 $0.07 $0.37 $0.50 $0.33 $0.13 $0.34 $0.39
Adjusted Weighted Average Basic Shares Outstanding
13.10M 13.09M 13.17M 13.16M 13.26M 13.24M 13.64M 13.62M 13.90M 13.88M 14.15M
Adjusted Diluted Earnings per Share
($0.08) $0.09 $0.89 $0.43 $0.06 $0.36 $0.48 $0.32 $0.12 $0.32 $0.36
Adjusted Weighted Average Diluted Shares Outstanding
13.10M 13.27M 13.47M 13.38M 13.48M 13.64M 14.30M 14.27M 14.53M 14.51M 14.56M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
12.99M 13.20M 13.18M 13.09M 13.27M 13.29M 13.43M 13.20M 13.85M 13.91M 13.90M
Normalized Net Operating Profit after Tax (NOPAT)
-1.02 2.57 12 6.19 2.53 5.43 6.89 4.56 1.77 4.92 5.84
Normalized NOPAT Margin
-1.71% 3.73% 14.16% 8.43% 4.12% 7.94% 8.84% 6.38% 2.86% 7.09% 7.41%
Pre Tax Income Margin
-2.26% 2.30% 21.39% 11.40% 2.31% 7.71% 13.40% 9.21% 4.50% 8.74% 10.51%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-9.33 8.29 88.32 33.78 4.40 15.63 25.78 18.57 6.91 15.59 21.60
NOPAT to Interest Expense
-6.53 6.17 58.69 23.10 2.72 14.37 16.81 12.87 4.32 12.00 14.56
EBIT Less CapEx to Interest Expense
-17.49 2.68 83.01 30.13 2.43 12.48 23.41 16.02 3.48 12.57 18.87
NOPAT Less CapEx to Interest Expense
-14.69 0.56 53.39 19.45 0.75 11.23 14.45 10.33 0.89 8.98 11.82
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
151.81% 103.36% 131.39% 173.77% 288.32% 284.04% 199.96% 179.32% 130.47% 109.91% 129.41%

Frequently Asked Questions About Franklin Covey's Financials

When does Franklin Covey's financial year end?

According to the most recent income statement we have on file, Franklin Covey's fiscal year ends in August. Their fiscal year 2024 ended on August 31, 2024.

How has Franklin Covey's net income changed over the last 2 years?

Franklin Covey's net income appears to be on an upward trend, with a most recent value of $23.40 million in 2024, rising from $18.43 million in 2022. The previous period was $17.78 million in 2023. See Franklin Covey's forecast for analyst expectations on what’s next for the company.

What is Franklin Covey's operating income?
Franklin Covey's total operating income in 2024 was $33.04 million, based on the following breakdown:
  • Total Gross Profit: $221.07 million
  • Total Operating Expenses: $188.03 million
How has Franklin Covey revenue changed over the last 2 years?

Over the last 2 years, Franklin Covey's total revenue changed from $262.84 million in 2022 to $287.23 million in 2024, a change of 9.3%.

How much debt does Franklin Covey have?

Franklin Covey's total liabilities were at $178.40 million at the end of 2024, a 6.7% increase from 2023, and a 1.2% increase since 2022.

How much cash does Franklin Covey have?

In the past 2 years, Franklin Covey's cash and equivalents has ranged from $38.23 million in 2023 to $60.52 million in 2022, and is currently $48.66 million as of their latest financial filing in 2024.

How has Franklin Covey's book value per share changed over the last 2 years?

Over the last 2 years, Franklin Covey's book value per share changed from 5.98 in 2022 to 6.35 in 2024, a change of 6.2%.



This page (NYSE:FC) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners